Shilpa Medicare is currently trading at Rs. 270.00, up by 10.35 points or 3.99% from its previous closing of Rs. 259.65 on the BSE.
The scrip opened at Rs. 260.50 and has touched a high and low of Rs. 275.00 and Rs. 260.50 respectively.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 546.95 on 14-Sep-2018 and a 52 week low of Rs. 190.80 on 04-Sep-2019.
Last one week high and low of the scrip stood at Rs. 275.00 and Rs. 190.80 respectively. The current market cap of the company is Rs. 2116.85 crore.
The promoters holding in the company stood at 53.80%, while Institutions and Non-Institutions held 26.59% and 19.60% respectively.
US Food and Drug Administration (USFDA) has concluded inspection at Shilpa Medicare’s Finished Dosage Formulation Facility (Sterile and Non-sterile Dosage Forms) located at S-20 to S-26, Pharmaceutical Formulations SEZ, APIIC, Jadcherla in the state of Telangana from August 29, 2019 to September 6, 2019.
The inspection concluded with two observations. There were no repeat observations or Data Integrity (DI) related observations.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
